Filing Flows › Staar Surgical (STAA) › Q2 2026 › vs Q1 2026
Staar Surgical (STAA) Q2 2026 vs Q1 2026 (quarter over quarter)
Staar Surgical's revenue rose $13K (0%) from $93.5M in Q1 2026 to $93.5M in Q2 2026. Gross margin 74.5% against 73.6% (+0.9 pts).
Staar Surgical, Q2 2026: revenue $93.5M (+111% year over year), operating margin 10.8%, net earnings $8.1M, operating cash flow $19.7M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 74.5% | 73.6% | +0.9 pts |
| Operating margin | 10.8% | 8.5% | +2.3 pts |
| Net margin | 8.6% | 5.6% | +3.0 pts |
| Free cash flow margin | 20.5% | -23.7% | +44.2 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $93.5M | $93.5M | $13K | 0% |
| Gross profit | $69.7M | $68.9M | $868K | +1% |
| Cost of revenue | $23.8M | $24.7M | −$855K | -3% |
| Other income, net | $923K | $239K | $684K | +286% |
| Operating profit | $10.1M | $8.0M | $2.1M | +27% |
| Operating expenses | $59.6M | $60.9M | −$1.3M | -2% |
| Pre-tax earnings | $11.0M | $8.2M | $2.8M | +34% |
| Net earnings | $8.1M | $5.2M | $2.9M | +55% |
| Income tax | $3.0M | $3.0M | −$46K | -2% |
| Depreciation | $2.4M | $2.1M | $283K | +13% |
| Share-based compensation | $6.6M | $4.8M | $1.7M | +36% |
| Working capital & other | $2.7M | −$33.8M | $36.5M | — |
| Operating cash flow | $19.7M | −$21.7M | $41.4M | — |
| Free cash flow (OCF − capex) | $19.2M | −$22.1M | $41.3M | — |
| Capital expenditures | $494K | $443K | $51K | +12% |
Questions
How much did Staar Surgical's revenue grow quarter over quarter in Q2 2026?
Staar Surgical's revenue rose $13K (0%) from $93.5M in Q1 2026 to $93.5M in Q2 2026. Gross margin 74.5% against 73.6% (+0.9 pts).